nach oben

Journal of Gastrointestinal Surgery

Erschienen in:

01.04.2012 | Original Article

Intraductal Papillary Mucinous Neoplasm (IPMN) with Extra-Pancreatic Mucin: A Case Series and Review of the Literature

verfasst von: Laura H. Rosenberger, Louis H. Stein, Agnieszka K. Witkiewicz, Eugene P. Kennedy, Charles J. Yeo

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Intraductal papillary mucinous neoplasm (IPMN) is an increasingly recognized pancreatic neoplasm characterized by excessive mucin secretion by ductal epithelial cells resulting in a cystic dilation of the pancreatic duct.

Aim

The objective of this study was to review Thomas Jefferson University’s experience and the literature to determine the significance of extra-pancreatic mucin when associated with an IPMN.

Results

A retrospective analysis at our institution revealed only two cases of IPMN associated with extra-pancreatic mucin, which were classic IPMNs with rupture of the pancreatic duct and peritoneal mucin spillage. This specific finding is not previously described, although is assumed as five cases were reported in the literature with IPMN and mucin extension demonstrated by pseudomyxoma peritonei (PMP). We propose IPMN of the pancreas may be grossly compared to a mucocele of the appendix, as both are characterized by excessive secretion of mucin by ductal epithelial cells. A morbid complication of a mucocele is PMP. The presence of extra-pancreatic mucin with an IPMN could present a rare but important marker of the eventual seeding of tumor outside the primary IPMN. This has been documented with cases of iatrogenic spilling of pancreatic mucin, as well as multiple cases of IPMN associated with pseudomyxoma peritonei.

Conclusions

At this time, there is scant reporting and consensus for the treatment of IPMN with extra-pancreatic mucin.

Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol. 2006; 40:856-862.PubMedCrossRef

Tanaka M. Intraductal papillary mucinous neoplasm of the pancreas: diagnosis and treatment. Pancreas. 2004; 28:282-288.PubMedCrossRef

Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006; 244:10-15.PubMedCrossRef

Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, Hodgin MB, Sauter PK, Hruban RH, Riall TS, Schulick RD, Choti MA, Lillemoe KD, Yeo CJ. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006; 10:1199-1210.PubMedCrossRef

Tollefson MK, Libsch KD, Sarr MG, Chari ST, DiMagno EP, Urrutia R, Smyrk TC. Intraductal papillary mucinous neoplasm: did it exist prior to 1980? Pancreas. 2003; 26:e55-58.PubMedCrossRef

Sarr MG, Murr M, Smyrk TC, Yeo CJ, Fernandez-del-Castillo C, Hawes RH, Freeny PC. Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance—current state-of-the-art and unanswered questions. J Gastrointest Surg. 2003; 7:417-428.PubMedCrossRef

Kobari M, Egawa S, Shibuya K, Shimamura H, Sunamura M, Takeda K, Matsuno S, Furukawa T. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999; 134:1131-1136.PubMedCrossRef

Ohashi K, Murakami Y, Takeoshi T, Ohta H, Ohashi I. Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater (Japanese). Prog Dig Endosc. 1982; 20:348-351.

Yamaguchi K, Tanaka M. Mucin-hypersecreting tumor of the pancreas with mucin extrusion through enlarged papilla. Am J Gastroenterol. 1991; 86:835-839.PubMed

10.

Kim HJ, Kim MH, Lee SK, Yoo KS, Park ET, Lim BC, Park HJ, Myung SJ, Seo DW, Min YI. Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy. 2000; 32:389-393.PubMedCrossRef

11.

Imaoka H, Yamao K, Salem AA, Mizuno N, Takahashi K, Sawaki A, Isaka T, Okamoto Y, Yanagisawa A, Shimizu Y. Pseudomyxoma peritonei caused by acute pancreatitis in intraductal papillary mucinous carcinoma of the pancreas. Pancreas. 2006; 32:223-224.PubMedCrossRef

12.

Trigg NA, El-Attar A, Berkelhammer C. Mucinous biliary obstruction in intraductal papillary mucinous neoplasm of the pancreas (IPMN): 615. Am J Gastroenterol. 2005; 100 Suppl 1:S233.

13.

Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD. Intraductal mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004; 239:788-797.PubMedCrossRef

14.

Takahashi Y, Sakamoto Y, Shimada K, Sano T, Kosuge T, Onaya H, Mizuguchi Y, Hiraoka N. Imaging features of large intraductal papillary mucinous carcinoma of the pancreatic tail. Pancreas. 2006; 32:333-334.CrossRef

15.

Zanelli M, Casadei R, Santini D, Gallo C, Verdirame F, La Donna M, Marrano D. Pseudomyxoma peritonei associated with intraductal papillary-mucinous neoplasm of the pancreas. Pancreas. 1998; 17:100-102.PubMedCrossRef

16.

Mizuta Y, Akazawa Y, Shiozawa K, Ohara H, Ohba K, Ohnita K, Isomoto H, Takeshima F, Omagari K, Tanaka K, Yasutake T, Nakagoe T, Shirono K, Kohno S. Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2005; 5:470-474.PubMedCrossRef

17.

Lee SE, Jang JY, Yang SH, Kim SW. Intraductal papillary mucinous carcinoma with atypical manifestations: report of two cases. World J Gastroenterol. 2007; 13:1622-1625.PubMedCrossRef

18.

Nepka CH, Potamianos S, Karadana M, Barbanis S, Kapsoritakis A, Koukoulis G. Ascitic fluid cytology in a rare case of pseudomyxoma peritonei originating from intraductal papillary mucinous neoplasm of the pancreas. Cytopathology. 2009; 20:271-273.PubMedCrossRef

19.

Bastid C, Bernard JP, Sarles H, Payan MJ, Sahel J. Mucinous ductal ectasia of the pancreas: a premalignant disease and a cause of obstructive pancreatitis. Pancreas. 1991; 6:15-22.PubMedCrossRef

20.

Warshaw AL. Mucinous cystic tumors and mucinous ductal ectasia of the pancreas. Gastrointest Endosc. 1991; 37:199-201.PubMedCrossRef

21.

Lew JI, Hart J, Michelassi F. Natural history of mucinous ductal ectasia of the pancreas: a case report and review of the literature. Am J Gastroenterol. 2002; 97:2127-2132.PubMedCrossRef

22.

Yamaguchi K, Ogawa Y, Chljiiwa K, Tanaka M. Mucin-hypersecreting tumors of the pancreas: assessing the grade of malignancy preoperatively. Am J Surg. 1996; 171:427-431.PubMedCrossRef

23.

Yamada M, Kozuka S, Yamao K, Nakazawa S, Naitoh Y, Tsukamoto Y. Mucin-producing tumor of the pancreas. Cancer. 1991; 68:159-168.PubMedCrossRef

24.

Obara T, Maguchi H, Saitoh Y, Itoh A, Arisato S, Ashida T, Nishino N, Ura H, Namiki M. Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes. Am J Gastroenterol. 1993; 88:564-569.PubMed

25.

Rickaert F, Cremer M, Deviere J, Tavares L, Lambilliotte JP, Schroder S, Wurbs D, Kloppel G. Intraductal mucin-hypersecreting neoplasms of the pancreas. A clinicopathologic study of eight patients. Gastroenterology. 1991; 101:512-519.PubMed

26.

Kloppel G. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. Hepatogastroenterology. 1998; 45:1981-1985.PubMed

27.

Loftus EV, Olivares-Pakzad BA, Batts KP, Adkins MC, Stephens DH, Sarr MG, Dimagno EP. Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Gastroenterology. 1996; 110:1909-1918.PubMedCrossRef

28.

Kloeppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. World Health Organization International Histological Classification of Tumours. Histological Typing of Tumours of the Exocrine Pancreas, 2nd ed. Berlin: Springer; 1996: 1-61.CrossRef

29.

Hruban RH, Pitman MB, Klimstra DS. Armed Forces Institute of Pathology Atlas of Tumor Pathology: Tumors of the Pancreas, Fascicle 6. Washington DC: American Registry of Pathology; 2007.

30.

Salvia R, Fernandez-del Castillo C, Bassi C, Thayer SP, Falconi M, Mantovani W, Pederzoli P, Warshaw AL. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004; 239:678-685.PubMedCrossRef

31.

Chari ST, Yadav D, Smyrk TC, DiMagno EP, Miller LJ, Raimondo M, Clain JE, Norton IA, Pearson RK, Petersen BT, Wiersema MJ, Farnell MB, Sarr MG. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002; 123:1500-1507.PubMedCrossRef

32.

Deans GT, Spence RA. Neoplastic lesions of the appendix. Br J Surg. 1995; 82:299-306.PubMedCrossRef

33.

de Rezende Pereira JC, Trugilho JC, Sarmat AA. Mucocele of the appendix. Surgery. 2004; 136:1096-1097.PubMedCrossRef

34.

Ruiz-Tovar J, Teruel G, Castineiras M, Dehesa S, Quindos L, Molina M. Mucocele of the appendix. World J Surg. 2007; 31:542-548.PubMedCrossRef

35.

Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg. 1998; 85:1332-1339.PubMedCrossRef

36.

Gonzalez Moreno S, Shmookler BM, Sugarbaker PH. Appendiceal mucocele. Contraindication to laparoscopic appendectomy. Surg Endosc. 1998; 12:1177-1179.PubMedCrossRef

37.

Dhage-Ivatury S, Sugarbaker PH. Update on the surgical approach to mucocele of the appendix. J Am Coll Surg. 2006; 202:680-684.PubMedCrossRef

38.

Weaver CH. Mucocele of appendix with pseudomucinous degeneration. Am J Surg. 1937; 36:523-526.CrossRef

39.

Werth R. Klinische und anatomische untersuchungen zur lehre von den bauchgeschwuelsten und der laparotomie. Arch Gynecol Obstet. 1884; 24:100-118.

40.

Frankel E. Uber das sogenannte pseudomyxoma peritonei. Muenchen Med Wochenschr. 1901; 48:965-970.

41.

Baradi H, Ponsky J. Pseudomyxoma peritonei. Surgery. 2002; 131:230-231.PubMedCrossRef

42.

Fann JI, Vierra M, Fisher D, Oberhelman HA Jr, Cobb L. Pseudomyxoma peritonei. Surg Gynecol Obstet. 1993; 177:441-447.PubMed

43.

Gough DB, Donohue JH, Schutt AJ, Gonchoroff N, Goellner JR, Wilson TO, Naessens JM, O’Brien PC, van Heerden JA. Pseudomyxoma peritonei: long-term patient survival with an aggressive regional approach. Ann Surg. 1994; 219:112-119.PubMedCrossRef

44.

Hawes D, Robinson R, Wira R. Pseudomyxoma peritonei from metastatic colloid carcinoma of the breast. Gastrointest Radiol. 1991; 16:80-82.PubMedCrossRef

45.

Sugarbaker PH, Kern K, Lack E. Malignant pseudomyxoma peritonei of colonic origin. Natural history and a presentation of a curative approach to treatment. Dis Colon Rectum. 1987; 30:772-779.PubMedCrossRef

46.

Koyama S, Tomimatsu T, Sawada K, Kanagawa T, Tsutsui T, Kimura T. Pseudomyxoma peritonei originating from colorectal cancer during pregnancy. J Obstet Gynaecol Res. 2011; 37:254-258.PubMedCrossRef

47.

Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol. 1995; 19:1390-1408.PubMedCrossRef

48.

Hirooka Y, Goto H, Itoh A, Hashimoto S, Niwa K, Ishikawa H, Okada N, Itoh T, Kawashima H. Case of intraductal papillary mucinous tumor in which endosonography-guided fine-needle aspiration biopsy caused dissemination. J Gastroenterol Hepatol. 2003; 18:1323-1324.PubMedCrossRef

49.

Yasuda H, Takada T, Amano H, Yoshida M. Surgery for mucin-producing pancreatic tumor. Hepato-gastroenterology. 1998; 45:2009-2015.PubMed

50.

Mann WJ, Wagner J, Chumas J, Chalas E. The management of pseudomyxoma peritonei. Cancer. 1990; 66:1636-1640.PubMedCrossRef

51.

Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol. 2004; 11:393-398.PubMedCrossRef

52.

Green N, Gancedo H, Smith R, Bernett G. Pseudomyxoma peritonei—nonoperative management and biochemical findings. A case report. Cancer. 1975; 36:1834-1837.PubMedCrossRef

53.

Sindelar WF, DeLaney TF, Tochner Z, Thomas GF, Dachoswki LJ, Smith PD, Friauf WS, Cole JW, Glatstein E. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg. 1991; 126:318-324.PubMedCrossRef

54.

Schomas DA, Miller RC, Donohue JH, Gill S, Thurmes PJ, Haddock MG, Quevedo JF, Gunderson LL. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience. Ann Surg. 2009; 249:588-595.PubMedCrossRef

55.

Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S. International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006; 6:17-32.PubMedCrossRef

Titel: Intraductal Papillary Mucinous Neoplasm (IPMN) with Extra-Pancreatic Mucin: A Case Series and Review of the Literature
verfasst von: Laura H. Rosenberger
Louis H. Stein
Agnieszka K. Witkiewicz
Eugene P. Kennedy
Charles J. Yeo
Publikationsdatum: 01.04.2012
Verlag: Springer-Verlag
Erschienen in: Journal of Gastrointestinal Surgery / Ausgabe 4/2012
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-012-1823-8

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Aim

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Outcomes for Consecutive Patients Undergoing Single-Site Laparoscopic Colorectal Surgery

Totally Laparoscopic Billroth II Gastrectomy with a Novel, Safe, Simple, and Time-Saving Anastomosis by Only Stapling Devices

Standard Radical Gastrectomy in Octogenarians and Nonagenarians with Gastric Cancer: Are Short-Term Surgical Results and Long-Term Survival Substantial?

Intraoperative Detection of Disappearing Colorectal Liver Metastases as a Predictor of Residual Disease

Extensive Mediastinal Lymphadenectomy During Minimally Invasive Esophagectomy: Optimal Results from a Single Center

Robotic Anterior RAMPS in Well-Selected Left-Sided Pancreatic Cancer

Update Chirurgie